Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-08-20Clinical Trial Update: An Add-On Trial of Quetiapine in Patients With Bipolar Disorder and Cocaine Dependence [Phase 4]
A Phase 4 add-on trial evaluated quetiapine for patients with bipolar disorder who also have cocaine dependence, and the study has completed…
-
CLINICAL_TRIALS research · 2012-08-16Clinical Trial Update: Internalized Stigma in Patients With Bipolar Disorder or Schizophrenia
ClinicalTrials.gov update describing a study on internalized stigma in patients with bipolar disorder or schizophrenia; the current status i…
-
CLINICAL_TRIALS trial_result · 2012-08-08Clinical Trial Update: Family Intervention for Mental Illness and Substance Abuse [NA]
A completed clinical trial evaluating a family intervention for mental illness and substance abuse.
-
FDA approval · 2012-08-02FDA Approved: RISPERDAL M-TAB — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The U.S. FDA approved a supplemental application for Risperdal M-TAB (risperidone) submitted by Janssen Pharmaceuticals, Inc.
-
FDA approval · 2012-08-01FDA Approved: LAMICTAL — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for Lamictal (lamotrigine) from GlaxoSmithKline LLC. This action may involve labeling or indication …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-08-01FDA Approved: LAMICTAL ODT — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for LAMICTAL ODT (lamotrigine) by GlaxoSmithKline LLC, updating the labeling for the oral disintegra…
-
FDA approval · 2012-08-01FDA Approved: LAMICTAL XR — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for LAMICTAL XR (lamotrigine) submitted by GlaxoSmithKline LLC.
-
FDA approval · 2012-07-27FDA Approved: RISPERIDONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for risperidone from Sun Pharmaceutical Industries under ANDA078474.
-
CLINICAL_TRIALS research · 2012-07-26Clinical Trial Update: A Study of the Association Between Tobacco Smoking and Bipolar Affective Disorder
This clinical trial update reports on a completed study examining the relationship between tobacco smoking and bipolar disorder.
-
FDA approval · 2012-07-25FDA Approved: LITHIUM CARBONATE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved a supplemental application for Lithium Carbonate from Glenmark Pharmaceuticals Inc., USA. The approval likely updates label…
-
CLINICAL_TRIALS trial_result · 2012-07-23Clinical Trial Update: Acute Treatment of Bipolar II Depression [Phase 3]
Phase 3 trial evaluating acute treatment for bipolar II depression has completed, as reported by Stanford University.
-
FDA approval · 2012-07-19FDA Approved: EPITOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for EPITOL (carbamazepine) from Teva Pharmaceuticals USA, Inc.
-
CLINICAL_TRIALS trial_result · 2012-07-17Clinical Trial Update: Effectiveness of Quetiapine XR on the Control of Symptoms of Manic Phase of Bipolar Disorder. [Phase 4]
Phase 4 trial results evaluating the effectiveness of quetiapine XR in controlling manic symptoms in bipolar disorder have been completed, w…
-
CLINICAL_TRIALS trial_result · 2012-07-12Clinical Trial Update: Quetiapine Fumarate (Seroquel) as Mono-Therapy or Adjunct to Lithium in the Treatment of Patients With Acute Mania in Bipolar Disorder [Phase 4]
Phase 4 clinical trial evaluating quetiapine fumarate as both monotherapy and as an adjunct to lithium for acute mania in bipolar disorder; …
-
CLINICAL_TRIALS trial_result · 2012-07-12Clinical Trial Update: Impact of Genetic Counseling for Individuals With Mental Illness [Phase 3]
This Phase 3 trial evaluating the impact of genetic counseling in individuals with schizophrenia, bipolar disorder, and schizoaffective diso…
-
CLINICAL_TRIALS trial_result · 2012-07-09Clinical Trial Update: One-Year Trial of Oral Ziprasidone in Bipolar Patients With Metabolic Syndrome [Phase 3]
Phase 3 trial of an oral ziprasidone regimen in bipolar disorder patients with metabolic syndrome was terminated; results were posted in 201…
-
CLINICAL_TRIALS trial_result · 2012-07-04Clinical Trial Update: Invega (Paliperidone) for the Treatment of Mania in Children and Adolescents Ages 6-17 With Bipolar Disorder [Phase 4]
Phase 4 trial update for paliperidone (Invega) in treating mania in children and adolescents with bipolar disorder. The study was terminated…
-
CLINICAL_TRIALS trial_result · 2012-06-29Clinical Trial Update: Efficacy and Safety of Quetiapine Versus Quetiapine Plus Lithium in Bipolar Depression [Phase 3]
Phase 3 trial comparing quetiapine alone versus quetiapine plus lithium in acute bipolar depression; results completed and posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-06-20Clinical Trial Update: Lamictal As Add on Treatment in Mixed States of Bipolar Disorder [Phase 4]
A Phase 4 trial evaluating Lamictal as an add-on treatment for mixed states in bipolar disorder has completed.
-
CLINICAL_TRIALS trial_result · 2012-06-20Clinical Trial Update: Interpersonal and Social Rhythm Therapy for Adolescents With Bipolar Disorder [NA]
This clinical trial update notes that the study evaluating Interpersonal and Social Rhythm Therapy for adolescents with bipolar disorder has…
-
FDA approval · 2012-06-19FDA Approved: CARBAMAZEPINE — Supplemental Application (Torrent Pharmaceuticals Limited)
The FDA approved a supplemental application for carbamazepine from Torrent Pharmaceuticals Limited. This represents a supplemental approval …
-
FDA approval · 2012-06-19FDA Approved: OLANZAPINE AND FLUOXETINE — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approved the original application for a fixed-dose combination of olanzapine and fluoxetine (olanzapine/fluoxetine) by Teva Pharmaceutic…
-
FDA approval · 2012-06-19FDA Approved: CARBAMAZEPINE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for Carbamazepine from Torrent Pharmaceuticals Limited.
-
CLINICAL_TRIALS trial_result · 2012-06-19Clinical Trial Update: A Eye Movement Desensitization Reprocessing (EMDR) Study in Bipolar Traumatized Patients [NA]
A clinical trial evaluating eye movement desensitization and reprocessing (EMDR) for bipolar disorder patients with trauma/PTSD has complete…
-
CLINICAL_TRIALS withdrawal · 2012-06-18Clinical Trial Update: Prazosin as an Antimanic Agent in Severe Mania or Mixed States [NA]
A clinical trial evaluating prazosin as an antimanic agent in bipolar mania or mixed states has been withdrawn.